β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis

被引：0
|
作者：
Uta Drebber
Martin Madeja
Margarete Odenthal
Inga Wedemeyer
Stefan P. Mönig
Jan Brabender
Elfriede Bollschweiler
Arnulf H. Hölscher
Paul M. Schneider
Hans P. Dienes
Daniel Vallböhmer
机构：
[1] University Hospital Cologne,Institute of Pathology
[2] University Hospital Cologne,Department of General, Visceral and Cancer Surgery
[3] University Hospital Zurich,Department of Visceral and Transplantation Surgery
来源：
International Journal of Colorectal Disease | 2011年 / 26卷
关键词：
Rectal cancer; Neoadjuvant therapy; Response prediction; Prognosis; β-catenin; Her2/neu;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Expression of Her2/Neu in gallbladder carcinomas and its implication for therapy
    Yamaguchi, M
    Okuyama, T
    GASTROENTEROLOGY, 2003, 124 (04) : A565 - A565
  • [32] Association between HER2/neu overexpression and calcifications in breast cancer
    Christy, C. J.
    Rishi, M.
    Schwartz, J.
    Grube, B. J.
    Bossuyt, V.
    Philpotts, L.
    DiGiovanna, M. P.
    Tavassoli, F.
    Lannin, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Loss of HER2 expression in HER2-positive breast cancer patients after neoadjuvant therapy
    Sang, Yuting
    Wu, Jiong
    Yang, Benlong
    CANCER RESEARCH, 2022, 82 (04)
  • [34] Stability of HER2 Expression in Residual Breast Cancer Following Neoadjuvant Anti-HER2 Therapy
    Mir, Mariam O.
    Sahoo, Sunati
    Fang, Yisheng
    Peng, Yan
    Hwang, Helena
    Czapla, Agata
    Koduru, Prasad
    Sarode, Venetia
    LABORATORY INVESTIGATION, 2018, 98 : 91 - 91
  • [35] Expression of Her2/neu in locally advanced bladder cancer:: Implication for a molecular targeted therapy
    Wülfing, C
    von Struensee, D
    Bierer, S
    Bögemann, M
    Hertle, L
    Eltze, E
    AKTUELLE UROLOGIE, 2005, 36 (05) : 423 - 429
  • [36] Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
    Heidy Cedeño
    Rafael Araúz
    Fernando Cebamanos
    Idalmis de Torraza
    Ana Porcell
    BMC Cancer, 7 (Suppl 1)
  • [37] Expression of Her2/neu in gastric adenocarcinomas
    Batistatou, A.
    Lampri, E.
    Kamina, S.
    Malamou-Mitsi, V.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 251 - 252
  • [38] Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer
    Paralta Branco, F.
    Silva, F.
    Andre, S.
    Catarino, A.
    Madureira, R.
    Moreira Pinto, J.
    Godinho, J.
    Simoes, P.
    Freitas, A. C.
    Casa-Nova, M.
    Nave, M.
    Augusto, J.
    Passos-Coelho, J. L.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S94 - S94
  • [39] HER2/neu Status on Pre and Post Neoadjuvant Chemotherapy
    Nofech-Mozes, S.
    Hanna, W.
    LABORATORY INVESTIGATION, 2009, 89 : 60A - 61A
  • [40] Study of the Effect of Neoadjuvant Chemotherapy on the Status of Her2/neu
    Skalova, H.
    Dundr, P.
    Povysil, C.
    Velenska, Z.
    Petruzelka, L.
    Tvrdik, D.
    FOLIA BIOLOGICA, 2011, 57 (05) : 191 - 199
12345